, Biochemical 303 outcome after radical prostatectomy, external beam radiation therapy, or 304 interstitial radiation therapy for clinically localized prostate cancer Dose-response 308 characteristics of low-and intermediate-risk prostate cancer treated with 309 external beam radiotherapy, Dose-volume effects for 312 normal tissues in external radiotherapy: pelvis, pp.305-969, 1998.
, Functional outcomes and 316 complications following radiation therapy for prostate cancer: a critical analysis 317 of the literature, Eur Urol, vol.61, p.112
, Is it time to tailor the 320 prediction of radio-induced toxicity in prostate cancer patients? Building the 321 first set of nomograms for late rectal syndrome, Int J Radiat Oncol Biol Phys, vol.322, pp.82-2012, 1957.
, Predictive models of toxicity with external radiotherapy for prostate cancer, Cancer, vol.72, issue.suppl 3, pp.3141-326
DOI : 10.1002/cncr.24356
, Gy versus 80 Gy in 329 localized prostate cancer: 5-year results of GETUG 06 randomized trial, Int J, pp.70-330
, Image-guided 333 Radiation Therapy (IGRT) in Prostate Cancer: Preliminary Results in Prostate 334 Registration and Acute Toxicity of a Randomized Study, Radiat Oncol Biol Phys Int J Radiat Oncol, vol.80, issue.335, pp.1056-331, 2011.
, American Joint Committee on Cancer: Manual for 338 Staging of Cancer, Biol Phys, vol.75, issue.9, p.99, 2009.
, LATE NORMAL TISSUE SEQUELAE IN THE SECOND DECADE AFTER HIGH DOSE RADIATION THERAPY WITH COMBINED PHOTONS AND CONFORMAL PROTONS FOR LOCALLY ADVANCED PROSTATE CANCER, The Journal of Urology, vol.167, issue.1, pp.123-345, 2002.
DOI : 10.1016/S0022-5347(05)65395-5
, Diabetes mellitus: a predictor for late radiation morbidity, International Journal of Radiation Oncology*Biology*Physics, vol.43, issue.3, pp.475-1831, 2009.
DOI : 10.1016/S0360-3016(98)00460-X
, External beam radiotherapy for 354 prostate cancer patients on anticoagulation therapy: how significant is the 355 bleeding toxicity? Evaluating urinary continence 358 and preoperative predictors of urinary continence after robot assisted 359 laparoscopic radical prostatectomy Is type 2 diabetes mellitus a 362 predictive factor for incontinence after laparoscopic radical prostatectomy? A 363 matched pair and multivariate analysis Prostate cancer 366 radiation dose response: results of the M. D. Anderson phase III randomized 367 trial Comparison of 370 conventional-dose vs high-dose conformal radiation therapy in clinically 371 localized adenocarcinoma of the prostate: a randomized controlled trial, et al.: Escalated-dose 375 versus standard-dose conformal radiotherapy in prostate cancer: first results 376 from the MRC RT01 randomised controlled trial, pp.755-356, 2010.
, Update of Dutch Multicenter Dose-Escalation Trial of Radiotherapy for Localized Prostate Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.72, issue.4, pp.980-1124, 2008381382.
DOI : 10.1016/j.ijrobp.2008.02.073
, Late outcomes following hypofractionated 388 conformal radiotherapy vs. standard fractionation for localized prostate cancer: 389 a nonrandomized contemporary comparison, Int J Radiat Oncol Biol Phys, vol.74, pp.390-1441
, Five-year follow-up of health- 393 related quality of life after intensity-modulated radiation therapy for prostate 394 cancer Ten-year outcomes of 397 = high-dose, intensity-modulated radiotherapy for localized prostate cancer. 398 Cancer Dosimetry guidelines to minimize 401 urethral and rectal morbidity following transperineal I-125 prostate 402 brachytherapy, Improved Clinical 405 Outcomes with High-Dose Image Guided Radiotherapy Compared with Non- 406 IGRT for the Treatment of Clinically Localized Prostate Cancer, pp.732-1429, 1995.